|
|||||
|
|
Effect of oral pancreatic enzyme administration on digestive function in healthy subjects: comparison between two enzyme preparations |
|
| Authors: | J. E. DOMÍ NGUEZ-MUÑ OZ,U. BIRCKELBACH,B. GLASBRENNER,T. SAUERBRUCH,& P. MALFERTHEINER |
| Affiliation: | Department of Gastroenterology, University of Magdeburg, Germany; Department of Internal Medicine, University of Bonn, Germany; Department of Internal Medicine, University of Ulm, Germany |
| Abstract: | Background : Intraduodenal proteases exert a negative feedback on pancreatic secretion. Aim : To investigate the effect of two pancreatic enzyme preparations (enteric-coated tablets, and capsules with enteric-coated microtablets) on postprandial pancreatic and bile acid secretion, gastroduodenal motility and release of gastrin and pancreatic polypeptide in healthy humans. Methods : Twenty healthy males were studied on two different days one week apart. After an overnight fast a nine-lumen motility tube was positioned with the distal tip at the Treitz angle. On each study day, 30 min after an interdigestive migrating motor complex-phase III, a semi-liquid test meal was given either alone ( n =20) or with enzymes (3 tablets ( n =10) or 2 capsules with microtablets ( n =10); 40000 U lipase and 2000 proteases) in a randomized order, and the study continued over 2 h. Motility was continuously recorded with four ports in the antrum and three in the duodenum, using a low-compliance pneumohydraulic perfusion system. Secretion of human-specific pancreatic elastase and bile acids was measured by a standard duodenal intubation perfusion technique. Plasma concentrations of gastrin and pancreatic polypeptide were measured by specific radioimmunoassays. Results : Postprandial pancreatic secretion was significantly reduced by administration of microtablets (median 82 mg/2 h vs. 70 mg/2 h, P <0.02) but not by tablets (median 59 mg/2 h vs. 58 mg/2 h, N.S.). No changes were observed in bile acid secretion, antroduodenal motility or release of gastrin and pancreatic polypeptide. Conclusions : Oral administration of pancreatic enzymes at normal therapeutic doses significantly inhibits postprandial pancreatic secretion in healthy humans, when capsules with enteric-coated microtablets are given. Exogenous pancreatic enzymes have no significant effect on bile acid secretion, gastroduodenal motility and hormone release. |
| Keywords: | |